Intermittent Leucine Deprivation Produces Long-lasting Improvement in Insulin Sensitivity by Increasing Hepatic Gcn2 Expression

• DOI: 10.2337/db21-0336
• Publication Date: 2021-11-05T15:10:10Z
• Authors: Hanrui Yin; Feixiang Yuan; Fuxin Jiao; Yuguo Niu; Xiaoxue Jiang; Jiali Deng; Yajie Guo; Shanghai Chen; Qiwei Zhai; Cheng Hu; Yiming Li; Feifan Guo
• Keywords: Male; Mice, Knockout; 0301 basic medicine; Protein Serine-Threonine Kinases; Gene Expression Regulation, Enzymologic; Epigenesis, Genetic; Mice, Inbred C57BL; Mice; 03 medical and health sciences; Liver; Leucine; Animals; Insulin; Female; Insulin Resistance; Cells, Cultured; Signal Transduction

Leucine deprivation improves insulin sensitivity; however, whether and how this effect can be extended are unknown. We hypothesized that intermittent leucine deprivation (ILD) might produce a long-term effect on improved insulin sensitivity via the formation of metabolic memory. Consistently, seven ILD cycles of treatment (1-day leucine-deficient diet, 3-day control diet) in mice produced a long-lasting (after a control diet was resumed for 49 days) effect on improved whole-body and hepatic insulin sensitivity in mice, indicating the potential formation of metabolic memory. Furthermore, the effects of ILD depended on hepatic general control nondepressible 2 (GCN2) expression, as verified by gain- and loss-of-function experiments. Moreover, ILD increased Gcn2 expression by reducing its DNA methylation at two CpG promoter sites controlled by demethylase growth arrest and DNA damage inducible b. Finally, ILD also improved insulin sensitivity in insulin-resistant mice. Thus, ILD induces long-lasting improvements in insulin sensitivity by increasing hepatic Gcn2 expression via a reduction in its DNA methylation. These results provide novel insights into understanding of the link between leucine deprivation and insulin sensitivity, as well as potential nutritional intervention strategies for treating insulin resistance and related diseases. We also provide evidence for liver-specific metabolic memory after ILD and novel epigenetic mechanisms for Gcn2 regulation.